Literature DB >> 15783026

Role of tissue trace elements in liver cancers and non-cancerous liver parenchyma.

Takashi Maeda1, Mitsuo Shimada, Norifumi Harimoto, Eiji Tsujita, Shin-ichiro Maehara, Tatsuya Rikimaru, Shiniji Tanaka, Ken Shirabe, Yoshihiko Maehara.   

Abstract

BACKGROUND/AIMS: The role of trace elements in liver fibrosis, carcinogenesis and progression of hepatocellular carcinoma (HCC) has not yet been clarified. The aim of this study is to analyze the characteristics of trace elements in liver cancers and non-cancerous liver and to discuss their role in hepatic fibrosis, hepatocarcinogenesis and progression of HCC.
METHODOLOGY: The amount of zinc (Zn), iron (Fe), and copper (Cu) in 20 HCCs, 2 cholangiocellular carcinomas (CCC), 7 metastatic liver cancers (Meta) and their non-tumorous liver parenchyma were measured using an atomic absorption spectrophotometer.
RESULTS: The amounts of Zn and Fe in non-tumorous liver parenchyma were reduced by liver fibrosis, and the amounts were lower in HCC tissue compared to non-tumorous liver parenchyma. The amounts of Zn and Cu were higher in HCC than the amounts found in CCC and Meta. The amount of Zn in HCC tissue decreased, but the amount of Fe increased in tumors more than 4cm in diameter.
CONCLUSIONS: These results suggest that the decrease in the amount of Zn and Fe found in non-tumorous liver parenchyma correlates with liver fibrosis leading to cirrhosis and hepatocarcinogenesis. Also that decreases in Zn and increases of Fe in HCC tissue correlates with HCC tumor progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15783026

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  9 in total

Review 1.  Zinc and liver disease.

Authors:  Mohammad K Mohammad; Mohammad K Mohommad; Zhanxiang Zhou; Matthew Cave; Ashutosh Barve; Craig J McClain
Journal:  Nutr Clin Pract       Date:  2012-02       Impact factor: 3.080

Review 2.  Molecular imaging and therapy targeting copper metabolism in hepatocellular carcinoma.

Authors:  Jason Wachsmann; Fangyu Peng
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 3.  The status of zinc in the development of hepatocellular cancer: an important, but neglected, clinically established relationship.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Cancer Biol Ther       Date:  2014-01-21       Impact factor: 4.742

4.  Chemopreventive effect of vanadium in a rodent model of chemical hepatocarcinogenesis: reflections in oxidative DNA damage, energy-dispersive X-ray fluorescence profile and metallothionein expression.

Authors:  Tridib Chakraborty; Amrita Chatterjee; Mahesh G Saralaya; Malay Chatterjee
Journal:  J Biol Inorg Chem       Date:  2006-07-08       Impact factor: 3.358

5.  Establishment of secondary iron overloaded mouse model: evaluation of cardiac function and analysis according to iron concentration.

Authors:  Se Na Moon; Ji Whan Han; Hui Seung Hwang; Mee Jeong Kim; Soon Ju Lee; Jae Young Lee; Chang Kyu Oh; Dae Chul Jeong
Journal:  Pediatr Cardiol       Date:  2011-06-09       Impact factor: 1.655

6.  Serum and tissue zinc in epithelial malignancies: a meta-analysis.

Authors:  Jaromir Gumulec; Michal Masarik; Vojtech Adam; Tomas Eckschlager; Ivo Provaznik; Rene Kizek
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

7.  Prohibitin-induced, obesity-associated insulin resistance and accompanying low-grade inflammation causes NASH and HCC.

Authors:  Sudharsana R Ande; K Hoa Nguyen; B L Grégoire Nyomba; Suresh Mishra
Journal:  Sci Rep       Date:  2016-03-23       Impact factor: 4.379

Review 8.  Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease.

Authors:  Takashi Himoto; Tsutomu Masaki
Journal:  Nutrients       Date:  2018-01-14       Impact factor: 5.717

9.  Hepatic copper and other trace mineral concentrations in dogs with hepatocellular carcinoma.

Authors:  Cailin C Harro; Rebecca C Smedley; John P Buchweitz; Daniel K Langlois
Journal:  J Vet Intern Med       Date:  2019-09-07       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.